Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 11;15(7):e41717.
doi: 10.7759/cureus.41717. eCollection 2023 Jul.

Dengue, Chikungunya, and Zika: The Causes and Threats of Emerging and Re-emerging Arboviral Diseases

Affiliations
Review

Dengue, Chikungunya, and Zika: The Causes and Threats of Emerging and Re-emerging Arboviral Diseases

Suha Soni et al. Cureus. .

Abstract

The recent emergence and re-emergence of viral infections transmitted by vectors, Zika, chikungunya, dengue, and others, is a cause for international concern. Here, we provide a summary of the current understanding of the transmission, clinical features, diagnosis, global burden, and the likelihood of future epidemics by these viruses. Arboviruses transmitted by mosquitoes are challenging to diagnose and can have surprising clinical complications. Dengue, chikungunya, and Zika are the most important diseases caused by arboviruses worldwide, especially in tropical and subtropical regions. These are transmitted to humans by day-biting Aedes aegypti and Aedes albopictus mosquitoes. In India, the increase in the incidence of dengue and chikungunya cases is primarily linked to the dissemination of Aedes aegypti. A rapid and accurate diagnosis is paramount for effectively controlling dengue outbreaks. As there is no vaccination or specific treatment available for these viruses, vector control is the only comprehensive solution available.

Keywords: chikungunya encephalitis; dengue fever (df); dengue hemorrhagic fever (dhf); dengue shock syndrome (dss); dengue thrombocytopenia; dengue virus infection; mosquito vector; sero-surveillance; vector borne diseases; zika infection.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Factors affecting the severity of dengue infection
IFN: interferon, APL: altered peptide ligand
Figure 2
Figure 2. DENV, antigen, and antibody responses used in diagnosis

References

    1. Present and future arboviral threats. Weaver SC, Reisen WK. Antiviral Res. 2010;85:328–345. - PMC - PubMed
    1. Estimating the risk of arbovirus transmission in Southern Europe using vector competence data. Mariconti M, Obadia T, Mousson L, Malacrida A, Gasperi G, Failloux AB, Yen PS. Sci Rep. 2019;9:17852. - PMC - PubMed
    1. Dengue virus: epidemiology, biology, and disease aetiology. Roy SK, Bhattacharjee S. Can J Microbiol. 2021;67:687–702. - PubMed
    1. Dengue and severe dengue. [ Jun; 2023 ]. 2023. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
    1. The global distribution and burden of dengue. Bhatt S, Gething PW, Brady OJ, et al. Nature. 2013;496:504–507. - PMC - PubMed

LinkOut - more resources